Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Kåre Schultz er på vej ud af ledelsen hos Teva — MedWatch
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Teva Appoints Lundbeck's Schultz as CEO | Ctech
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Sådan har Teva-aktien udviklet sig under Kåre Schultz
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz | Fierce Pharma
In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Teva CEO steps down, replacement found — MedWatch
Where is Kåre Schultz? | Ctech
Business-update: Kåre Schultz forgyldt med lønforhøjelse på op til 26 mio. kroner
Kåre Schultz får stor lønstigning i Teva
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
Kåre Schultz vil stoppe i Teva efter 2023: “Det bliver nok mere bestyrelsesarbejde”
Teva denies outgoing CEO board role — MedWatch
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Nedtælling for Kåre Schultz: “Inden for de næste 12 måneder vil de finde min afløser”
Kåre Schultz fyrer 40 folk om dagen - og det er langtfra slut
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Serial Problem Solver
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
